文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

早期有创机械通气与2019冠状病毒病肺炎相关急性低氧性呼吸衰竭60天死亡率的相关性

Association Between Early Invasive Mechanical Ventilation and Day-60 Mortality in Acute Hypoxemic Respiratory Failure Related to Coronavirus Disease-2019 Pneumonia.
PubMed 文献 · Crit Care Explor · 2021-01-22
一句话结论在COVID-19相关急性低氧性呼吸衰竭ICU患者中,ICU入住前2个日历日内启动有创机械通气与60天死亡风险增加相关(加权HR 1.74)。

这项法国11个ICU的多中心前瞻性观察研究纳入245例COVID-19相关急性低氧性呼吸衰竭(PaO2/FiO2≤300 mm Hg)且入ICU时无休克或神经功能衰竭的患者,比较ICU入住前2个日历日内接受有创机械通气(早期组,n=117)与未接受者(非早期组,n=128)的60天死亡率。早期组60天死亡率为42.7%,非早期组为21.9%;经逆概率加权Cox模型显示早期有创机械通气增加60天死亡风险(加权HR=1.74;95%CI 1.07-2.83,P=0.03)。早期组ICU获得性肺炎、菌血症发生率和ICU住院时间显著更高(P<0.01)。作者结论认为该结果需进一步确认。

要点

  • 早期有创机械通气组60天死亡率为42.7%,非早期组为21.9%,加权HR=1.74(95%CI 1.07-2.83,P=0.03)。
  • 早期组(n=117)ICU获得性肺炎、菌血症发生率和ICU住院时间显著高于非早期组(n=128),P<0.01。
  • 纳入标准为COVID-19相关急性低氧性呼吸衰竭(PaO2/FiO2≤300 mm Hg),入ICU时无休克或神经功能衰竭。
  • 早期有创机械通气定义为ICU入住前2个日历日内接受有创机械通气。
  • 作者结论认为早期有创机械通气与60天死亡风险增加相关,该结果需进一步确认。

适用人群与场景

  • COVID-19患者,急性低氧性呼吸衰竭(PaO2/FiO2≤300 mm Hg),入ICU时无休克或神经功能衰竭,且非由其他ICU或中间监护病房转入者。

诊断标准与关键阈值

  • 急性低氧性呼吸衰竭定义:PaO2/FiO2≤300 mm Hg。
  • 早期有创机械通气定义:ICU入住前2个日历日内接受有创机械通气。

研究设计与关键结果

  • 研究类型:法国OutcomeRea网络11个ICU的多中心前瞻性观察研究,纳入245例患者。
  • 人群基线:中位年龄61岁(四分位距52-69岁),Simplified Acute Physiology Score II 34(26-44),PaO2/FiO2 121 mm Hg(90-174 mm Hg)。
  • 分组:早期有创机械通气组n=117(48%),非早期组n=128(52%)。
  • 主要终点:60天死亡率早期组42.7% vs 非早期组21.9%;加权Cox模型显示早期有创机械通气增加60天死亡风险(加权HR=1.74;95%CI 1.07-2.83,P=0.03)。
  • 次要终点:ICU获得性肺炎、菌血症发生率和ICU住院时间早期组显著高于非早期组(P<0.01)。

证据类型、等级与局限

  • 证据类型:多中心前瞻性观察研究。
  • 局限:作者结论指出该结果需进一步确认。

对床旁实践的改变

  • 作者结论认为,在因COVID-19相关急性低氧性呼吸衰竭入ICU的患者中,早期有创机械通气与60天死亡风险增加相关,该结果需进一步确认。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: About 5% of patients with coronavirus disease-2019 are admitted to the ICU for acute hypoxemic respiratory failure. Opinions differ on whether invasive mechanical ventilation should be used as first-line therapy over noninvasive oxygen support. The aim of the study was to assess the effect of early invasive mechanical ventilation in coronavirus disease-2019 with acute hypoxemic respiratory failure on day-60 mortality.

DESIGN: Multicenter prospective French observational study.

SETTING: Eleven ICUs of the French OutcomeRea network.

PATIENTS: Coronavirus disease-2019 patients with acute hypoxemic respiratory failure (Pao2/Fio2 ≤ 300 mm Hg), without shock or neurologic failure on ICU admission, and not referred from another ICU or intermediate care unit were included.

INTERVENTION: We compared day-60 mortality in patients who were on invasive mechanical ventilation within the first 2 calendar days of the ICU stay (early invasive mechanical ventilation group) and those who were not (nonearly invasive mechanical ventilation group). We used a Cox proportional-hazard model weighted by inverse probability of early invasive mechanical ventilation to determine the risk of death at day 60.

MEASUREMENT AND MAIN RESULTS: The 245 patients included had a median (interquartile range) age of 61 years (52-69 yr), a Simplified Acute Physiology Score II score of 34 mm Hg (26-44 mm Hg), and a Pao2/Fio2 of 121 mm Hg (90-174 mm Hg). The rates of ICU-acquired pneumonia, bacteremia, and the ICU length of stay were significantly higher in the early (n = 117 [48%]) than in the nonearly invasive mechanical ventilation group (n = 128 [52%]), p < 0.01. Day-60 mortality was 42.7% and 21.9% in the early and nonearly invasive mechanical ventilation groups, respectively. The weighted model showed that early invasive mechanical ventilation increased the risk for day-60 mortality (weighted hazard ratio =1.74; 95% CI, 1.07-2.83, p=0.03).

CONCLUSIONS: In ICU patients admitted with coronavirus disease-2019-induced acute hypoxemic respiratory failure, early invasive mechanical ventilation was associated with an increased risk of day-60 mortality. This result needs to be confirmed.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Dupuis C, Bouadma L, de Montmollin E, et al. Association Between Early Invasive Mechanical Ventilation and Day-60 Mortality in Acute Hypoxemic Respiratory Failure Related to Coronavirus Disease-2019 Pneumonia. Crit Care Explor. 2021. PMID: 33521646. doi:10.1097/CCE.0000000000000329

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。